BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36809483)

  • 1. Artificial intelligence-assisted cancer diagnosis improves the efficiency of pathologists in prostatic biopsies.
    Eloy C; Marques A; Pinto J; Pinheiro J; Campelos S; Curado M; Vale J; Polónia A
    Virchows Arch; 2023 Mar; 482(3):595-604. PubMed ID: 36809483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study.
    Pantanowitz L; Quiroga-Garza GM; Bien L; Heled R; Laifenfeld D; Linhart C; Sandbank J; Albrecht Shach A; Shalev V; Vecsler M; Michelow P; Hazelhurst S; Dhir R
    Lancet Digit Health; 2020 Aug; 2(8):e407-e416. PubMed ID: 33328045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies.
    Raciti P; Sue J; Ceballos R; Godrich R; Kunz JD; Kapur S; Reuter V; Grady L; Kanan C; Klimstra DS; Fuchs TJ
    Mod Pathol; 2020 Oct; 33(10):2058-2066. PubMed ID: 32393768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy.
    Perincheri S; Levi AW; Celli R; Gershkovich P; Rimm D; Morrow JS; Rothrock B; Raciti P; Klimstra D; Sinard J
    Mod Pathol; 2021 Aug; 34(8):1588-1595. PubMed ID: 33782551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent real-world application of a clinical-grade automated prostate cancer detection system.
    da Silva LM; Pereira EM; Salles PG; Godrich R; Ceballos R; Kunz JD; Casson A; Viret J; Chandarlapaty S; Ferreira CG; Ferrari B; Rothrock B; Raciti P; Reuter V; Dogdas B; DeMuth G; Sue J; Kanan C; Grady L; Fuchs TJ; Reis-Filho JS
    J Pathol; 2021 Jun; 254(2):147-158. PubMed ID: 33904171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Use of Combined Artificial Intelligence and Pathologist Assessment to Review and Grade Prostate Biopsies.
    Steiner DF; Nagpal K; Sayres R; Foote DJ; Wedin BD; Pearce A; Cai CJ; Winter SR; Symonds M; Yatziv L; Kapishnikov A; Brown T; Flament-Auvigne I; Tan F; Stumpe MC; Jiang PP; Liu Y; Chen PC; Corrado GS; Terry M; Mermel CH
    JAMA Netw Open; 2020 Nov; 3(11):e2023267. PubMed ID: 33180129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
    Ström P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Lindskog C; Ruusuvuori P; Wählby C; Grönberg H; Rantalainen M; Egevad L; Eklund M
    Lancet Oncol; 2020 Feb; 21(2):222-232. PubMed ID: 31926806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Validation of Artificial Intelligence-Augmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection.
    Raciti P; Sue J; Retamero JA; Ceballos R; Godrich R; Kunz JD; Casson A; Thiagarajan D; Ebrahimzadeh Z; Viret J; Lee D; Schüffler PJ; DeMuth G; Gulturk E; Kanan C; Rothrock B; Reis-Filho J; Klimstra DS; Reuter V; Fuchs TJ
    Arch Pathol Lab Med; 2023 Oct; 147(10):1178-1185. PubMed ID: 36538386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry in the workup of prostate biopsies: Frequency, variation and appropriateness of use among pathologists practicing at an academic center.
    Al Diffalha S; Shaar M; Barkan GA; Wojcik EM; Picken MM; Pambuccian SE
    Ann Diagn Pathol; 2017 Apr; 27():34-42. PubMed ID: 28325359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial intelligence system shows performance at the level of uropathologists for the detection and grading of prostate cancer in core needle biopsy: an independent external validation study.
    Jung M; Jin MS; Kim C; Lee C; Nikas IP; Park JH; Ryu HS
    Mod Pathol; 2022 Oct; 35(10):1449-1457. PubMed ID: 35487950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of an Artificial Intelligence-Powered Platform for Prostate Cancer Grading and Quantification.
    Huang W; Randhawa R; Jain P; Iczkowski KA; Hu R; Hubbard S; Eickhoff J; Basu H; Roy R
    JAMA Netw Open; 2021 Nov; 4(11):e2132554. PubMed ID: 34730818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Artificial Intelligence-based Support Tool for Automation and Standardisation of Gleason Grading in Prostate Biopsies.
    Marginean F; Arvidsson I; Simoulis A; Christian Overgaard N; Åström K; Heyden A; Bjartell A; Krzyzanowska A
    Eur Urol Focus; 2021 Sep; 7(5):995-1001. PubMed ID: 33303404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies.
    Scattoni V; Roscigno M; Freschi M; Dehò F; Raber M; Briganti A; Fantini G; Nava L; Montorsi F; Rigatti P
    Arch Ital Urol Androl; 2005 Mar; 77(1):31-6. PubMed ID: 15906787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies.
    Van der Kwast TH; Evans A; Lockwood G; Tkachuk D; Bostwick DG; Epstein JI; Humphrey PA; Montironi R; Van Leenders GJ; Pihl CG; Neetens I; Kujala PM; Laurila M; Mazerolles C; Bubendorf L; Finelli A; Watson K; Srigley J
    Am J Surg Pathol; 2010 Feb; 34(2):169-77. PubMed ID: 20061936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
    Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
    J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns in immunohistochemical usage in extended core prostate biopsies: comparisons among genitourinary pathologists and nongenitourinary pathologists.
    Plourde A; Gross A; Jiang Z; Owens CL
    Arch Pathol Lab Med; 2013 Nov; 137(11):1630-4. PubMed ID: 24168501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the Pathologist on Prostate Biopsy Diagnosis and Immunohistochemical Stain Usage Within a Single Institution.
    Shah MD; Parwani AV; Zynger DL
    Am J Clin Pathol; 2017 Nov; 148(6):494-501. PubMed ID: 29165567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic expert consultation using digital still images for evaluation of atypical small acinar proliferations of the prostate: a comparison with immunohistochemistry.
    Banihashemi A; Asgari M; Shooshtarizade T; Abolhasani M; Mireskandari M
    Ann Diagn Pathol; 2014 Jun; 18(3):163-70. PubMed ID: 24767894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice patterns of clinicians following isolated diagnoses of atypical small acinar proliferation on prostate biopsy specimens.
    Fadare O; Wang S; Mariappan MR
    Arch Pathol Lab Med; 2004 May; 128(5):557-60. PubMed ID: 15086303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
    Bulten W; Pinckaers H; van Boven H; Vink R; de Bel T; van Ginneken B; van der Laak J; Hulsbergen-van de Kaa C; Litjens G
    Lancet Oncol; 2020 Feb; 21(2):233-241. PubMed ID: 31926805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.